Melasma. Other disorders of pigmentation
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: In each session, 1 cc of stem cell conditioning medium is injected into one side of the patients face. The treatment is given twice, two weeks a
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: People with melasma on the cheeks and other areas of the face
Exclusion criteria
Exclusion criteria: Any complication that is related to the treatment process or is not tolerated by the patient The patient does not want to continue treatment for any reason Cancers, pregnancy, lactation, DVT, pulmonary embolism, stroke Incidence of drug allergies Occurrence of hypertrophic or colloidal scars at the treatment site
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Melasma area recovery rate. Timepoint: Before treatment and 1 month after the last session of treatment. Method of measurement: Visioface. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain level. Timepoint: In this project, we have two treatment sessions two weeks apart. The pain level after the injection in the two groups will be recorded in each session by the patient using a 1 to 10 scoring method. Method of measurement: Question about the level of pain during the injection, with a rating of 1 to 10.;Satisfaction. Timepoint: 1 month after the second treatment session. Method of measurement: Satisfaction level question with a rating of 1 to 10. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem Cell Research Center of Tehran University of Medical Sciences
Outcome results
None listed